Skip to main content

AHL suspends Brad Mills 20 games for failing performance-enhancing drug test

Brad Mills, who has played 34 NHL games with Chicago and New Jersey and is playing for Binghamton of the American League this year, tested positive for a performance-enhancing drug and was hit with a significant suspension.
The Hockey News

The Hockey News

The American Hockey League announced Tuesday a 20-game suspension for Binghamton Senators Brad Mills after he tested positive for a performance-enhancing drug.

The 31-year-old Mills, who had one goal and two points in 34 games of NHL experience with the New Jersey Devils and Chicago Blackhawks, was in his first year in Binghamton after an eight-year AHL career that included stops in Lowell, Albany and Rockford; he has already sat out four games after the Senators removed him from the lineup last week once the test result came in, and he’s eligible to return to the lineup Dec. 12.

Mills, a former team MVP at Yale University in 2003-04, has already apologized through the Professional Hockey Players’ Association for the failed test, which is now administered by the same doctors who supervise the NHL/NHL Players’ Association’s performance-enhancing substances program and substance abuse program. The AHL did not disclose what substance Mills tested positive for, but the bigger concern for him is failing another test: in accordance with AHL policy, a second failed test – all of which are randomly administered to players – will result in a 60-game suspension, and a third failed test results in the player being banned for life (with the chance to apply for reinstatement in two years).

TOP HEADLINES

Cam Talbot and Mitch Marner
Play

The Ottawa Senators Face an Anxious Start with Cam Talbot's Injury

Cam Talbot was expected to be the new starting goaltender for the Ottawa Senators. But after suffering a broken rib, it's up to Anton Forsberg to carry the load.

Hockey Canada

What You Need To Know After Hockey Canada's Hearing From Oct. 4

The Standing Committee on Canadian Heritage questioned the former chair and current interim chair of Hockey Canada's board of directors about aspects of its leadership and handling of sexual assault cases.

Marc-Andre Fleury
Play

Stat Pack: Who’s Hot And Who's Not In The 2022 NHL Pre-Season?

Who's impressing or disappointing the most in the NHL's pre-season? What does it mean with the small sample sizes? Carol Schram takes a look.